(Boursier.com) — The biotechnology company Cellectis will hold its Extraordinary General Meeting on December 22 at 2:30 p.m. Paris time at the Biopark site auditorium in Paris.
The notice of meeting as published today in the BALO (Bulletin of Obligatory Legal Announcements), including the agenda, the text of the resolutions and the terms of participation. It is online on the Cellectis website.
On the agenda of the Extraordinary General Meeting
Shareholders will have to decide on:
– the creation of a category of preferred shares called “class A preferred shares” (A Shares) convertible into ordinary shares – the determination of the specific rights attached to the A Shares; correlative modification of the statutes,
– the delegation of authority to be granted to the Board of Directors with a view to increasing the share capital by a maximum nominal amount of €500,000, by issuing a maximum number of 10,000,000 A Shares, with removal of the right preferential subscription (DPS) of shareholders for the benefit of a named person,
– the creation of a category of preferred shares called “category B preferred shares” (B Shares) convertible into ordinary shares – the determination of the specific rights attached to the B Shares; correlative modification of the statutes,
– the delegation of authority to be granted to the Board of Directors with a view to increasing the share capital by a maximum nominal amount of €900,000, by issuing a maximum number of 18,000,000 B Shares, with deletion of the PSR shareholders for the benefit of a named person,
– the removal of shareholders’ preferential subscription rights for the benefit of the company AstraZeneca Holdings BV,
– the delegation of authority to be granted to the Board of Directors for the purpose of carrying out an increase in the share capital, the subscription of which would be reserved for members of a company savings plan.
Finally, within the framework of the ordinary general meetingshareholders will also have to decide on the appointment of two directors.
©2023 Boursier.com